125 related articles for article (PubMed ID: 462583)
21. [Treatment of advanced breast cancer with cyclophosphamide, methotrexate, 5-fluorouracil and prednisone (CMFP)].
Rabinovich MG; Leone BA; Landó O
Medicina (B Aires); 1981; 41(1):65-70. PubMed ID: 7266359
[No Abstract] [Full Text] [Related]
22. [Gastrointestinal tumors: chemotherapeutic preparations].
Queisser W; Heim ME
Fortschr Med; 1983 Apr; 101(13):583-6. PubMed ID: 6852723
[TBL] [Abstract][Full Text] [Related]
23. Excess of serum copper not related to ceruloplasmin in Alzheimer disease.
Squitti R; Pasqualetti P; Dal Forno G; Moffa F; Cassetta E; Lupoi D; Vernieri F; Rossi L; Baldassini M; Rossini PM
Neurology; 2005 Mar; 64(6):1040-6. PubMed ID: 15781823
[TBL] [Abstract][Full Text] [Related]
24. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
[TBL] [Abstract][Full Text] [Related]
25. [Intermittent polychemotherapy in inoperable bronchial cancer].
Sighart H; Wrbka E; Simml G
Wien Med Wochenschr; 1972 Aug; 122(33):485-9. PubMed ID: 4115554
[No Abstract] [Full Text] [Related]
26. The prognosis and management of recurrent abdominal malignancies.
Griffen WO; Humphrey L; Sosin H
Curr Probl Surg; 1969 Apr; ():3-41. PubMed ID: 4183076
[No Abstract] [Full Text] [Related]
27. Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.
Neijt JP; van Lindert AC; Vendrik CP; Roozendaal KJ; Struyvenberg A; Pinedo HM
Cancer Treat Rep; 1980; 64(2-3):323-6. PubMed ID: 6773656
[TBL] [Abstract][Full Text] [Related]
28. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
Chylak V; Ilijas M; Krusić J; Kolarić K
Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
[No Abstract] [Full Text] [Related]
29. Serum copper, ceruloplasmin, protein thiols and thiobarbituric acid reactive substance status in liver cancer associated with elevated levels of alpha-fetoprotein.
Nayak SB; Yashwanth S; Pinto SM; Bhat VR; Mayya SS
Indian J Physiol Pharmacol; 2005; 49(3):341-4. PubMed ID: 16440854
[TBL] [Abstract][Full Text] [Related]
30. [Chemotherapy of cervical cancer].
Pawlicki M; Janowska E; Wiernik-Strzeszyńska E
Nowotwory; 1982; 32(3):139-44. PubMed ID: 6185928
[No Abstract] [Full Text] [Related]
31. [Polychemotherapy of advanced cancer of the breast].
Mascia V; Massidda B; Pellegrini A
Minerva Med; 1978 May; 69(26):1803-8. PubMed ID: 662182
[TBL] [Abstract][Full Text] [Related]
32. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
[TBL] [Abstract][Full Text] [Related]
33. Therapy of advanced colorectal carcinoma with 5-fluorouracil and cyclophosphamide in combination with either CCNU or methotrexate.
White DR; Richards F; Muss HB; Cooper MR; Spurr CL
Cancer; 1980 Feb; 45(4):662-5. PubMed ID: 6986968
[TBL] [Abstract][Full Text] [Related]
34. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
[No Abstract] [Full Text] [Related]
35. Advances in the multimodal primary management of cancer.
DeVita VT; Henney JE; Weiss RB
Adv Intern Med; 1980; 26():115-29. PubMed ID: 7013437
[No Abstract] [Full Text] [Related]
36. Cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy versus chloroethyl-cyclohexy-nitrosourea in the treatment of metastatic prostatic cancer.
Herr HW
J Urol; 1982 Mar; 127(3):462-5. PubMed ID: 7062419
[TBL] [Abstract][Full Text] [Related]
37. Comparison of CMF (cyclophosphamide, methotrexate, and 5-fluorouracil) with a rotational crossing and a sequential intensification regimen in advanced breast cancer: a prospective randomized study.
Cocconi G; Bisagni G; Bella M; Acito L; Anastasi P; Carpi A; Di Costanzo F; Frassoldati A; Mosconi A; Borrini A; Buzzi P
Am J Clin Oncol; 1999 Dec; 22(6):593-600. PubMed ID: 10597744
[TBL] [Abstract][Full Text] [Related]
38. Ceruloplasmin levels in sera from human patients with osteosarcoma.
Shifrine M; Fisher GL
Cancer; 1976 Jul; 38(1):244-8. PubMed ID: 1065468
[TBL] [Abstract][Full Text] [Related]
39. Metronomic chemotherapy against cancer: from paradigm to clinical practice?
Calvani N; Orlando L; Nacci A; Sponziello F; Cinefra M; Cinieri S
Tumori; 2009; 95(6):843-5. PubMed ID: 20210257
[TBL] [Abstract][Full Text] [Related]
40. Four drug combination cytotoxic chemotherapy following surgery for breast cancer.
Edelstyn GA; Bates IS; Brinkley D; MacRae KD; Spittle H; Wheeler T
Recent Results Cancer Res; 1978; 68():109-12. PubMed ID: 752851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
